The opioid crisis has made it even more urgent to come up with novel approaches to treating suffering. Finally there’s something effective.

Odyssey and Sionna swelled the pack of startups that will provide a look at how receptive public investors could be to biotech listings in 2025.

For patients in the -103 trial, 289 received Trikafta and 284 received Alyftrek over 52 weeks, according to the study.

The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and doctors say that's great news.

New report finds that Trikafta patients’ admissions to hospital fell by an average of 65 per cent over one year – but at a list price of over $300,000, the drug is not yet considered cost ...

From a young age, Emily Naismith watched her peers die from cystic fibrosis. The drug Trikafta gave her a future but she says forming a new identity has been complex.

Doctors started to see hints that Trikafta in utero could help babies with CF too. Of the hundreds of children born to mothers on Trikafta, only a few of the babies had CF themselves.

Trikafta corrects the misshapen protein that causes cystic fibrosis; this molecular tweak thins mucus in the lungs so it can be coughed up easily.

Vertex: The once-daily triple combination treatment, called vanza triple, met the primary goals of the study's two 52-week trials and was non-inferior for lung function to Trikafta, the company's ...

Vertex Pharmaceuticals' cystic fibrosis treatment with vanza triple therapy. SKYLINE trials show non-inferiority to Trikafta, emphasizing once-daily dosing benefits.

Set the bar and then beat it; that's what Vertex Pharmaceuticals has just done with a next-gen cystic fibrosis treatment.

Cystic fibrosis patients in Saskatchewan who are two to five years of age will be eligible for Trikafta as the province announced coverage for those who meet medical criteria.